Skip to content
COVID19, Medical Health Aged Care

Chronic fatigue condition offers clues to Long COVID

La Trobe University 2 mins read

New research by La Trobe University has uncovered the intricate relationship between two debilitating conditions, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID; offering insights into disease pathologies and potential treatment avenues.

The review article, Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies, studied both diseases in tandem to unlock a deeper understanding of their shared characteristics and unique molecular abnormalities.

Lead author Dr Sarah Annesley, Head of La Trobe’s Molecular Cell Biology Laboratory, investigated the disease pathologies which highlighted the significant overlap between the two conditions, with approximately half of Long COVID patients meeting the diagnostic criteria for ME/CFS.

“Research into both disorders is mutually beneficial as Long COVID can provide a unique opportunity to study early disease changes and map these changes over the duration of the disease,” Dr Annesley said.

“Conversely the ME/CFS research, which typically involves patients with a longer disease duration, may provide clues as to the future disease pathology of Long COVID.”

While the two conditions share clinical similarities and proposed disease pathologies, it remains unclear if they also share common molecular abnormalities.

“Most consistently altered pathologies in ME/CFS and Long COVID include an increased reliance on alternatives to carbohydrates as substrates for energy production and altered gut microbiota, with a reduction in butyrate-synthesising bacteria,” Dr Annesley said.

The review highlighted promising early results in therapeutic interventions targeting autoimmune responses in ME/CFS and Long COVID, which will require further clinical trials.

The research identified potential signs in the body, known as biomarkers, which could help doctors diagnose and track these conditions better. It was found measuring certain types of RNA could be the most accurate and clinically practicable clues for ME/CFS. However, their accuracy and clinical use require replication and validation in larger samples.

“Leveraging insights into both disorders may accelerate progress towards improving the lives of people affected by these debilitating conditions,” Dr Annesley said.

Dr Annesley’s paper coincides with the announcement of two La Trobe ME projects which have been awarded grants to conduct further studies into the condition, including one with Dr Annesley as an investigator. This project will examine how the different pathologies of ME/CFS and Long COVID interact, such as alterations in the gut, microbiota, the immune system and metabolism.

Link to paper here.

Media Contact
Jess Whitty - j.whitty@latrobe.edu.au, 0481 383 817

 

More from this category

  • Medical Health Aged Care
  • 20/04/2024
  • 04:30
Dementia Australia

Join us TODAY for Bendigo Memory Walk & Jog

What: Dementia Australia’sBendigoMemory Walk & Jog When: Saturday 20 April, from 8am Who: More than 390 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Bendigo Botanic Gardens, Bendigo For more information visit: www.memorywalk.com.au Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people…

  • Contains:
  • Medical Health Aged Care, Science
  • 19/04/2024
  • 15:00
Monash University

Large-scale genetic study finds new link between Irritable Bowel Syndrome and the cardiovascular system

New research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). Led by Dr Leticia Camargo Tavares, a Postdoctoral Fellow at the Hypertension Research Laboratory within Monash University’s School of Biological Sciences, the study reveals novel insights into the genetic underpinnings of IBS, offering potential avenues for therapeutic intervention. IBS is one of the most prevalent gastrointestinal disorders globally, affecting up to 10 per cent of the population, with a disproportionate impact on women. It is characterised by a complex range of symptoms…

  • Medical Health Aged Care
  • 19/04/2024
  • 11:13
Gilead Sciences Australia

Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program

– Gilead Sciences joins forces with World Hepatitis Alliance and experts to drive progress on viral hepatitis elimination targets – – Australian initiatives well represented in Gilead’s US$4 million global fund to empower local communities in the fight against viral hepatitis – Melbourne, Australia, 19 April 2024 – Today, on World Liver Day, Gilead Sciences Australia has announced nine local community organisations addressing viral hepatitis will receive a combined AU$400,000 via the global Gilead ALL4LIVER Grant. The recipients were selected by an independent external review panel of global experts, including the World Hepatitis Alliance. Australia has committed to achieving the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.